You have 9 free searches left this month | for more free features.

CURATE.AI

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumor Trial in Singapore (CURATE.AI, Nivolumab)

Recruiting
  • Solid Tumor
  • Singapore, Singapore
    National University Hospital
Jun 29, 2022

Hypertension, Cardiovascular Diseases Trial (Curate.AI, Telemonitoring)

Not yet recruiting
  • Hypertension
  • Cardiovascular Diseases
  • Curate.AI
  • Telemonitoring
  • (no location specified)
Jul 19, 2022

Solid Tumor, Gastrointestinal Cancer, Breast Cancer Trial in Singapore (QPOP, CURATE.AI, Azacitidine + docetaxel)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • QPOP
  • +4 more
  • Singapore, Singapore
    National University Hospital
May 18, 2022

Solid Tumor Trial in Singapore (CURATE.AI, Capecitabine, XELOX)

Recruiting
  • Solid Tumor
  • CURATE.AI
  • +4 more
  • Singapore, Singapore
  • +1 more
Dec 14, 2021

Cognitive Decline Trial in Singapore (CURATE.AI)

Recruiting
  • Cognitive Decline
  • CURATE.AI
  • Singapore, Singapore
  • +1 more
Nov 10, 2021

Diabetes, Hypertension Trial (CURATE.AI)

Not yet recruiting
  • Diabetes Mellitus
  • Hypertension
  • CURATE.AI
  • (no location specified)
Jul 21, 2021

Multiple Myeloma Trial in Singapore (Bortezomib, Cyclophosphamide, Dexamethasone)

Unknown status
  • Multiple Myeloma
  • Singapore, Singapore
    National University Hospital
Jan 23, 2020

Mild to Moderate Dementia Trial in Toronto (Music and Theta Auditory Beat Stimulation, Audiobooks)

Recruiting
  • Mild to Moderate Dementia
  • Music and Theta Auditory Beat Stimulation
  • Audiobooks
  • Toronto, Ontario, Canada
    LUCID Therapeutics
May 9, 2023

Healthy Trial in Singapore (Conventional training, AI-led training)

Unknown status
  • Healthy
  • Conventional training
  • AI-led training
  • Singapore, Singapore
    National University of Singapore
Apr 30, 2020

Radioresistance of Ependymomas in Children and Adolescents

Recruiting
  • Ependymoma of Brain
  • Pediatric Solid Tumor
    • Toulouse, France
      Institut Claudius Regaud
    Dec 8, 2021